Roivant Sciences (ROIV) Other financing activities (2020 - 2025)
Roivant Sciences (ROIV) posted Other financing activities of $1.2 million for Q4 2025, up 103.94% on a QoQ basis from -$29.3 million in Q3 2025, and down 96.88% year-over-year from $37.0 million in Q4 2024.
Roivant Sciences (ROIV) Other financing activities (2020 - 2025) Analysis & Trends
Roivant Sciences' Other financing activities history runs 4 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- Quarterly Other financing activities fell 96.88% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $38.9 million (down 59.83% YoY) and the FY2025 annual result came in at $49.6 million, up 991840.0% from the prior year.
- Other financing activities was $1.2 million for Q4 2025 at Roivant Sciences, up from -$29.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $51.0 million in Q4 2023 and bottomed at -$29.3 million in Q3 2025.
- A 3-year average of $11.0 million and a median of $6.6 million in 2024 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 1223.51% in 2025, while the deepest fall reached 542.34% in 2025.
- Roivant Sciences' Other financing activities stood at $51.0 million in 2023, then fell by 27.47% to $37.0 million in 2024, then sank by 96.88% to $1.2 million in 2025.
- Business Quant data shows ROIV's Other financing activities at $1.2 million in Q4 2025, -$29.3 million in Q3 2025, and $30.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | -29.28 Mn |
| Sep 30, 2025 | -29.28 Mn |
| Jun 30, 2025 | 30.06 Mn |
| Jun 30, 2025 | 30.06 Mn |
| Dec 31, 2024 | 37.01 Mn |
| Dec 31, 2024 | 37.01 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Sep 30, 2024 | 6.62 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Jun 30, 2024 | 2.27 Mn |
| Dec 31, 2023 | 51.02 Mn |
| Dec 31, 2023 | 51.02 Mn |
| Sep 30, 2023 | -20.44 Mn |
| Sep 30, 2023 | -20.44 Mn |
| Jun 30, 2023 | 21.03 Mn |
| Jun 30, 2023 | 21.03 Mn |
| Dec 31, 2020 | 725,000.00 |
| Dec 31, 2020 | 725,000.00 |